VEGF and podocytes in diabetic nephropathy.

VEGF and podocytes in diabetic nephropathy.
复制标题

DOI:
10.1016/j.semnephrol.2012.06.010
复制
发表时间:
2012-07
影响因子:
3.3
通讯作者:
Veron, Delma
Veron, Delma
中科院分区:
医学2区
文献类型:
--
作者:
Tufro, Alda;Veron, Delma

文献摘要

参考文献

被引文献

相似文献

Vascular endothelial growth factor-a (VEGF-A) is a protein secreted by podocytes that is necessary for survival of endothelial cells, podocytes and mesangial cells. VEGF-A regulates slit-diaphragm signaling and podocyte shape via VEGFR2-nephrin-nck-actin interactions. Chronic hyperglycemia-induced excess podocyte VEGF-A and low endothelial nitric oxide drive the development and the progression diabetic nephropathy. The abnormal cross talk between VEGF-A and NO pathways is fueled by the diabetic milieu increased oxidative stress. Recent findings on these pathogenic molecular mechanisms provide new potential targets for therapy for diabetic renal disease.
DOI: 10.1056/nejmoa0707330
发表时间: 2008-03-13
影响因子: 158.5
作者:
Eremina, Vera;Jefferson, J. Ashley;Quaggin, Susan E.
通讯作者: Quaggin, Susan E.
DOI: 10.1016/j.jdiacomp.2007.11.011
发表时间: 2008-09-01
影响因子: 3
作者:
Ezzidi, Intissar;Mtiraoui, Nabil;Almawi, Wassim Y.
通讯作者: Almawi, Wassim Y.
DOI: 10.2353/ajpath.2007.060610
发表时间: 2007-01-01
影响因子: 6
作者:
Forbes, Michael S.;Thornhill, Barbara A.;Chevalier, Robert L.
通讯作者: Chevalier, Robert L.
DOI: 10.1046/j.1464-5491.2000.00350.x
发表时间: 2000-09-01
期刊: DIABETIC MEDICINE
影响因子: 3.5
作者:
Chiarelli, F;Spagnoli, A;Verrotti, A
通讯作者: Verrotti, A
DOI: 10.2337/diabetes.51.10.3090
发表时间: 2002-10-01
期刊: DIABETES
影响因子: 7.7
作者:
Flyvbjerg, A;Dagnæs-Hansen, F;Rasch, R
通讯作者: Rasch, R